These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35316021)

  • 1. Effect of the MAGL/FAAH Dual Inhibitor JZL-195 on Streptozotocin-Induced Alzheimer's Disease-like Sporadic Dementia in Mice with an Emphasis on Aβ, HSP-70, Neuroinflammation, and Oxidative Stress.
    Bajaj S; Zameer S; Jain S; Yadav V; Vohora D
    ACS Chem Neurosci; 2022 Apr; 13(7):920-932. PubMed ID: 35316021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?
    Bajaj S; Jain S; Vyas P; Bawa S; Vohora D
    Brain Res Bull; 2021 Sep; 174():305-322. PubMed ID: 34217798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice.
    Wise LE; Long KA; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
    ACS Chem Neurosci; 2012 May; 3(5):369-78. PubMed ID: 22860205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer's Disease.
    Kanwal H; Sangineto M; Ciarnelli M; Castaldo P; Villani R; Romano AD; Serviddio G; Cassano T
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.
    Sakin YS; Dogrul A; Ilkaya F; Seyrek M; Ulas UH; Gulsen M; Bagci S
    Neurogastroenterol Motil; 2015 Jul; 27(7):936-44. PubMed ID: 25869205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain.
    Della Pietra A; Krivoshein G; Ivanov K; Giniatullina R; Jyrkkänen HK; Leinonen V; Lehtonen M; van den Maagdenberg AMJM; Savinainen J; Giniatullin R
    J Headache Pain; 2023 Apr; 24(1):38. PubMed ID: 37038131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorative effect of alendronate against intracerebroventricular streptozotocin induced alteration in neurobehavioral, neuroinflammation and biochemical parameters with emphasis on Aβ and BACE-1.
    Zameer S; Kaundal M; Vohora D; Ali J; Kalam Najmi A; Akhtar M
    Neurotoxicology; 2019 Jan; 70():122-134. PubMed ID: 30481507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the endocannabinoid degrading enzymes FAAH and MAGL during zebrafish embryogenesis alters sensorimotor function.
    Khara LS; Amin MR; Ali DW
    J Exp Biol; 2022 May; 225(9):. PubMed ID: 35438163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
    Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia-reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathway.
    Çakır M; Aydın A; Tekin S
    Int Immunopharmacol; 2023 Jan; 114():109586. PubMed ID: 36700769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
    Jaiswal S; Ayyannan SR
    ChemMedChem; 2021 Jul; 16(14):2172-2187. PubMed ID: 33834617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canagliflozin Mitigated Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice: Role of AMPK/SIRT-1 Signaling Pathway in Modulating Neuroinflammation.
    Khamies SM; El-Yamany MF; Ibrahim SM
    J Neuroimmune Pharmacol; 2024 Jul; 19(1):39. PubMed ID: 39073453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of carbamate derivatives as fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.
    Jaiswal S; Gupta G; Ayyannan SR
    Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200081. PubMed ID: 35924298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.
    Bedse G; Bluett RJ; Patrick TA; Romness NK; Gaulden AD; Kingsley PJ; Plath N; Marnett LJ; Patel S
    Transl Psychiatry; 2018 Apr; 8(1):92. PubMed ID: 29695817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice.
    Yesilyurt O; Cayirli M; Sakin YS; Seyrek M; Akar A; Dogrul A
    Arch Dermatol Res; 2016 Jul; 308(5):335-45. PubMed ID: 27126057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models.
    Parker LA; Limebeer CL; Rock EM; Sticht MA; Ward J; Turvey G; Benchama O; Rajarshi G; Wood JT; Alapafuja SO; Makriyannis A
    Psychopharmacology (Berl); 2016 Jun; 233(12):2265-75. PubMed ID: 27048155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
    Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
    Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitors.
    Ren SY; Wang ZZ; Zhang Y; Chen NH
    Acta Pharmacol Sin; 2020 Oct; 41(10):1263-1271. PubMed ID: 32203086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Aβ
    Singh L; Singh S
    Neurosci Lett; 2023 Mar; 799():137090. PubMed ID: 36690059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.